首页> 外国专利> CD300c Pharmaceutical composition comprising inhibitors of CD300c's expression or activation for preventing or treating of cancer

CD300c Pharmaceutical composition comprising inhibitors of CD300c's expression or activation for preventing or treating of cancer

机译:CD300C药物组合物,其包含CD30C表达或活化的抑制剂,用于预防或治疗癌症

摘要

The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising an inhibitor of CD300c expression or activity, and the like. It is expected that it can be effectively used as an immunotherapeutic agent in the treatment of various cancers because it can increase the number of cancer cells and reduce the number of bone marrow-derived suppressor cells, as well as effectively inhibit the growth and development of cancer.
机译:本发明涉及用于预防或治疗包含CD30C表达或活性抑制剂等癌症的药物组合物。 预期可以有效地用作治疗各种癌症的免疫治疗剂,因为它可以增加癌细胞的数量并减少骨髓衍生的抑制细胞的数量,并有效抑制生长和发展 癌症。

著录项

  • 公开/公告号KR102320280B1

    专利类型

  • 公开/公告日2021-11-29

    原文格式PDF

  • 申请/专利权人 주식회사 센트릭스바이오;

    申请/专利号KR20190061067

  • 发明设计人 전재원;정준구;이수인;

    申请日2019-05-24

  • 分类号A61K39/395;A61K39;A61K45/06;A61P35;

  • 国家 KR

  • 入库时间 2022-08-24 22:32:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号